COMPLICATION:

ETIOLOGY:
Abnormalities of the aortic valve leaflets AORTIC
Heart failure
Dilation of the aortic root REGURGITATION
MEDICAL MANAGEMENT:
DIASTOLIC
Manifestation: REGURGITATIO (M) ACE Inhibitors
N (M) Inotropes
- Dsypnea
(M) Diuretics
- Weakness
(M) Vasodilators
- Fatigue LV STROKE AORTIC (M) Vasodilators
- Hypotension VOLUME VOLUME DIASTOLIC EFFCTIV
(M) Dihydropyridine Calcium
- Edema PRESSURE E
Channel blockers
- Palpitations
- Orthopnea LV LEFT
- Lung crackles MASS SYSTOLI VENTRICLUA MYOCARDIAL FATIG
- Tachycardia C R EJECTION O₂ SUPPLY
- Cool TIME
(Nd) Fatigue r/t disease process
extremities
MYOCARDIA LV (N) Set practical goals with patient
L O₂ DYSFUNC MYOCARDIA (N) Aid the patient with developing a
TREATMENT MODALITIES: DIASTOLIC
TION L O₂ schedule for daily activity and rest.
TIME
Emphasize the importance of frequent
(T) Healthy lifestyle
LEFT rest periods.
SURGICAL MANAGEMENT: VENTRICLU (N) Instruct client in ways to monitor
AR MYOCARDIA responses to activity and significant
(S) Aortic valve replacement EJECTION L ISCHEMIA signs or symptoms.

DYSPN
LV
FAILURE
(Nd) Ineffective breathing pattern
(N) Note rate and depth of respirations, and type of With treatment, the 10 year survival for patients with
breathing pattern mild to moderate aortic regurgitation is 80 to 95 percent.
(N) Encourage slower/deeper respirations, use of With approximately timed valve replacement, long term
pursed-lip technique prognosis for patients with moderate to severe AR is good.
(N) Encourage and assist the client in performing However, the prognosis for those with severe AR is poorer.
relaxation technique